The following article was featured in:
Source:
National News
05/19/2025.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
In March 23andMe said that...
Continue on to full article...
